Literature DB >> 20596702

Spontaneous meso-portal shunt following orthotopic liver transplantation in a child.

Grégory Vannevel1, Philippe Clapuyt, Raymond Reding, Renaud Menten.   

Abstract

Post-transplant children are regularly followed by colour Doppler US exam. Liver parenchyma, biliary tract and portal, subhepatic and arterial vascularisation are checked. We observed a post-transplant child with spontaneous meso-portal bypass after portal vein thrombosis (PVT). After orthotopic liver transplantation (OLT), PVT is frequently observed. When it occurs early (before 3 weeks), it has been identified as a cause of graft failure. On the other hand, late PVT (after 3 weeks) can be extremely well-tolerated, with cavernous transformation of the portal vein and formation of hepatopetal collaterals that deliver blood to the liver. However, extrahepatic portal hypertension (EHPH) and its related complications can develop. Cavernoma transformation is usually seen, but spontaneous shunt is not yet described in transplant patients. Distinction from the classic cavernoma can be achieved by the depiction of a single transcapsular vessel. This bypass partially corrects the EHPH. However it was decided to completely prevent shunt development by performing a surgical mesenterico-left portal vein bypass.

Entities:  

Mesh:

Year:  2010        PMID: 20596702     DOI: 10.1007/s00247-010-1758-8

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  8 in total

1.  Effectiveness of Rex shunt in the treatment of portal hypertension.

Authors:  Roshni Dasgupta; Eve Roberts; Riccardo A Superina; Peter C Kim
Journal:  J Pediatr Surg       Date:  2006-01       Impact factor: 2.545

2.  Original extrahilar approach for hepatic portal revascularization and relief of extrahepatic portal hypertension related to later portal vein thrombosis after pediatric liver transplantation. Long term results.

Authors:  J de Ville de Goyet; P Gibbs; P Clapuyt; R Reding; E M Sokal; J B Otte
Journal:  Transplantation       Date:  1996-07-15       Impact factor: 4.939

3.  Hepatopetal collaterals after portal vein thrombosis following liver transplantation.

Authors:  A B Zajko; K M Bron
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

4.  Experience with the Rex shunt (mesenterico-left portal bypass) in children with extrahepatic portal hypertension.

Authors:  D A Bambini; R Superina; P S Almond; P F Whitington; E Alonso
Journal:  J Pediatr Surg       Date:  2000-01       Impact factor: 2.545

Review 5.  Recent concepts regarding extra-hepatic portal hypertension.

Authors:  Frédéric Gauthier
Journal:  Semin Pediatr Surg       Date:  2005-11       Impact factor: 2.754

Review 6.  [Portal cavenorma: diagnosis, aetiologies and consequences].

Authors:  Eric Vibert; Daniel Azoulay; Denis Castaing; Henri Bismuth
Journal:  Ann Chir       Date:  2002-12

7.  Vascular complications after liver transplantation: a 5-year experience.

Authors:  P Wozney; A B Zajko; K M Bron; S Point; T E Starzl
Journal:  AJR Am J Roentgenol       Date:  1986-10       Impact factor: 3.959

8.  Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography.

Authors:  A M De Gaetano; M Lafortune; H Patriquin; A De Franco; B Aubin; K Paradis
Journal:  AJR Am J Roentgenol       Date:  1995-11       Impact factor: 3.959

  8 in total
  2 in total

1.  Case report of a modified Meso-Rex bypass as a treatment technique for late-onset portal vein cavernous transformation with portal hypertension after adult deceased-donor liver transplantation.

Authors:  Dongdong Han; Rui Tang; Liang Wang; Ang Li; Xin Huang; Shan Shen; Jiahong Dong
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 2.  Technical Aspects and Considerations of Meso-Rex Bypass Following Liver Transplantation With Left Lateral Segment Grafts: Case Report and Review of the Literature.

Authors:  Christina Dalzell; Paola A Vargas; Kyle Soltys; Frank Di Paola; George Mazariegos; Nicolas Goldaracena
Journal:  Front Pediatr       Date:  2022-04-25       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.